Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-CAR011 in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
NCT03483688Phase 1Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of C-CAR011 in B-cell non-Hodgkin lymphoma, sponsored by Peking Union Medical College Hospital. Primary endpoint: Adverse Events at 12 weeks. Started Mar 2018; status: completed.
02
Drugs
C-CAR011
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT03483688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03483688.